Results per Page:
Calling in the backup: expanding DCs to augment vaccine responses
From the Fling and Cheever CITN Central Immune Monitoring Lab, Vaccine and Infectious Disease Division and Clinical Research Division
Dr. Martin 'Mac' Cheever, cancer immunotherapy expert, receives distinguished service award
Honor recognizes his work establishing Cancer Immunotherapy Trials Network
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
On immunotherapy trial, long-term survivors of deadly skin cancer point to a hopeful future
Once unheard-of survival rates seen among patients with advanced Merkel cell carcinoma
Seattle team pivotal to FDA OK on drug for rare skin cancer
UW Medicine and Fred Hutch had key roles in clinical trial of immunotherapy option for often-lethal Merkel cell cancer
Meet Global Oncology's deputy program head
Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Immunotherapy trial in rare skin cancer named one of 2016’s major advances in clinical cancer research and care
Study found long-lasting responses to immunotherapy drug in patients with Merkel cell carcinoma
'Finally showing hope': Immunotherapy trial results transforming care for rare skin cancer
Immunotherapy trial results transforming care for rare skin cancer
Scratching the surface of a rare skin cancer
Immune-boosting therapy shows promise for advanced Merkel cell carcinoma
Fred Hutchinson Cancer Research Center to lead immunotherapy clinical trials network
More than two dozen research institutes in the U.S. and Canada to participate